DNMT3A and heart failure: It should be noted that, by comparing circulating cells from patients with established heart failure with versus without DNMT3A CHIP driver mutations, the observed effects are demonstrated on top of the presence of heart failure, which, by itself, is known to be associated with inflammatory activation of circulating blood cells.